Cardiorenal Syndrome in Acute Kidney Injury.


Journal

Seminars in nephrology
ISSN: 1558-4488
Titre abrégé: Semin Nephrol
Pays: United States
ID NLM: 8110298

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 5 1 2019
pubmed: 5 1 2019
medline: 3 7 2019
Statut: ppublish

Résumé

Varying degrees of cardiac and kidney dysfunction commonly are observed in hospitalized patients. As a demonstration of the significant interplay between the heart and kidneys, dysfunction or injury of one organ often contributes to dysfunction or injury of the other. The term cardiorenal syndrome (CRS) was proposed to describe this complex organ cross-talk. Type 3 CRS, also known as acute renocardiac syndrome, is a subtype of CRS that occurs when acute kidney injury contributes to or precipitates the development of acute cardiac dysfunction. Acute kidney injury may directly or indirectly produce acute cardiac dysfunction by way of volume overload, metabolic acidosis, electrolyte disorders such as hyperkalemia and hypocalcemia, and other mechanisms. In this review, we examine the definition, epidemiology, pathophysiology, and treatment options for CRS with an emphasis on type 3 CRS.

Identifiants

pubmed: 30606406
pii: S0270-9295(18)30154-2
doi: 10.1016/j.semnephrol.2018.10.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-40

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Luca Di Lullo (L)

Department of Nephrology and Dialysis, L. Parodi-Delfino Hospital, Colleferro (Rome), Italy. Electronic address: dilulloluca69@gmail.com.

Patrick Bronson Reeves (PB)

Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Antonio Bellasi (A)

Research, Innovation and Brand Reputation, ASST (Azienda Socio Sanitaria Territoriale) Papa Giovanni XXIII, Bergamo, Italy.

Claudio Ronco (C)

International Renal Research Institute, S. Bortolo Hospital, Vicenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH